Evidence map›Paper›PMID 42511668›Full record

ArticleInternational journal of molecular sciences2026

Increased Cannabinoid Receptor 1-Immunopositive Perisomatic Input of Principal Cells in Human Epileptic Patients in Focal Cortical Dysplasia Type IIB.

Cecília Szekeres-Paraczky, Péter Szocsics, Loránd Erőss, Orsolya S Mihály, Zsófia Maglóczky

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cecília Szekeres-ParaczkySzentágothai János Doctoral School of Neuroscience, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-7071-7520
Péter SzocsicsSzentágothai János Doctoral School of Neuroscience, Semmelweis University, 1085 Budapest, Hungary.
Loránd ErőssDepartment of Functional Neurosurgery and Center of Neuromodulation, National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.
Orsolya S MihályDepartment of Pathology, St. Borbála Hospital, 2800 Tatabánya, Hungary.
Zsófia MaglóczkySzentágothai János Doctoral School of Neuroscience, Semmelweis University, 1085 Budapest, Hungary.

Funding

National Research, Development and Innovation Office National Research, Development, and Innovation Office (NKFI, Hungary, grant number K 125436
6 · The paper itself

Abstract

Drug-resistant epilepsy is often associated with a neurodevelopmental disorder, focal cortical dysplasia (FCD). As demonstrated by numerous studies, defects in perisomatic inhibition may play a role in the formation of seizures. In our previous study, we observed an increase in parvalbumin-immunopositive perisomatic input. It has been observed that other perisomatic inhibitory cells expressing cannabinoid receptor type-1 (CB1R) and containing cholecystokinin (CCK) sprout in epileptic hippocampi. Therefore, we have investigated whether CB1R-immunopositive innervation has also changed in FCD. FCDIIB surgical samples were compared to controls with short post-mortem delay. The perisomatic input contacting principal cells was examined by NeuN-CB1R double immunostaining. Quantification in 3D was performed using a confocal fluorescence microscope. The results show that the CB1R-immunopositive synaptic input of principal cells is significantly larger in FCD cases. This condition may be an adaptive response to abnormal activity, or it may be a pre-existing pathology that is exacerbated by seizures. The reorganisation of the perisomatic inhibitory system has the potential to further increase the seizure probability in both cases. It should be noted that alterations in both PV- and CCK-CB1R-expressing basket cells may be implicated in seizure generation.

Indexed as

EpilepsyFocal Cortical DysplasiaMalformations of Cortical Development, Group IReceptor, Cannabinoid, CB1AdolescentAdultChildChild, PreschoolFemaleHippocampusHumansMaleNeuronsParvalbuminsYoung AdultParvalbuminsReceptor, Cannabinoid, CB1cannabinoid receptor 1dysmorphic neuronsfocal cortical dysplasiahuman cortexinterneuronsperisomatic inhibition

Identifiers

PMID42511668
PMCPMC13409960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.